Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS-193884 is an oral endothelin antagonist for the treatment of congestive heart failure (CHF) and pulmonary arterial hypertension.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | BMS-193884 is an oral endothelin antagonist for the treatment of congestive heart failure (CHF) and pulmonary arterial hypertension. |
ターゲット&IC50 | ETB:18700 nM (Ki), ETA:1.4 nM (Ki) |
別名 | BMS193884, BMS 193884 |
分子量 | 395.43 |
分子式 | C20H17N3O4S |
CAS No. | 176960-47-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS-193884 176960-47-7 BMS193884 BMS 193884 Inhibitor inhibitor inhibit